Abstract：Objective To evaluate the condition of subclinical cardiac damage in children with primary hypertension and the association between serum uric acid and subclinical cardiac damage. Methods A retrospective analysis was performed on the medical data of 55 children who were hospitalized and diagnosed with primary hypertension in the Department of Cardiology, Children's Hospital of Soochow University from January 2015 to June 2020. Forty-five healthy children, matched for age and sex, were enrolled as the control group. The two groups were compared in terms of clinical features, laboratory examination, and parameters for left ventricular structure, systolic function, and diastolic function. The correlation of serum uric acid with the parameters for left ventricular structure, systolic function, and diastolic function in children with primary hypertension was analyzed. Results Compared with the control group, the hypertension group had significantly higher left ventricular mass (LVM), left ventricular mass index (LVMI), and relative wall thickness (RWT) (P < 0.05). Among the children with primary hypertension, 20 (36%) had left ventricular hypertrophy. The hypertension group had significantly larger left atrial diameter and aortic root diameter than the control group (P < 0.05). The hypertension group had a significantly higher ratio of early diastolic mitral inflow velocity to early diastolic mitral annular velocity than the control group (P < 0.05). The correlation analysis showed that in children with primary hypertension, serum uric acid was positively correlated with LVM (r=0.534, P < 0.01), left atrial diameter (r=0.459, P < 0.01), and aortic root diameter (r=0.361, P=0.010). After adjustment for blood pressure, serum uric acid was still positively correlated with the above parameters (P < 0.05). Conclusions Children with primary hypertension may have subclinical cardiac damage such as left ventricular hypertrophy, left ventricular diastolic dysfunction, left atrial enlargement, and proximal aortic dilation. Elevated serum uric acid is significantly associated with cardiac damage in children with primary hypertension.
HOU Miao,SUN Ling,ZHOU Wan-Ping et al. Association between serum uric acid and subclinical cardiac damage in children with primary hypertension[J]. CJCP, 2021, 23(2): 174-179.
Wirix AJ, Nauta J, Groothoff JW, et al. Is the prevalence of hypertension in overweight children overestimated?[J]. Arch Dis Child, 2016, 101(11):998-1003.
[2]
Wühl E. Hypertension in childhood obesity[J]. Acta Paediatr, 2019, 108(1):37-43.
[3]
Taylor DA. Hypertensive crisis:a review of pathophysiology and treatment[J]. Crit Care Nurs Clin North Am, 2015, 27(4):439-447.
[4]
Kuwabara M, Hisatome I, Niwa K, et al. Uric acid is a strong risk marker for developing hypertension from prehypertension:a 5-year Japanese cohort study[J]. Hypertension, 2018, 71(1):78-86.
[5]
De Becker B, Borghi C, Burnier M, et al. Uric acid and hypertension:a focused review and practical recommenda-tions[J]. J Hypertens, 2019, 37(5):878-883.
[6]
Kanbay M, Girerd N, Machu JL, et al. Impact of uric acid on hypertension occurrence and target organ damage:insights from the STANISLAS cohort with a 20-year follow-up[J]. Am J Hypertens, 2020, 33(9):869-878.
[7]
Wang J, Qin TQ, Chen JR, et al. Hyperuricemia and risk of incident hypertension:a systematic review and meta-analysis of observational studies[J]. PLoS One, 2014, 9(12):e114259.
[8]
Li H, Qian FD, Liu HY, et al. Elevated uric acid levels promote vascular smooth muscle cells (VSMC) proliferation via an nod-like receptor protein 3(NLRP3)-inflammasome-dependent mechanism[J]. Med Sci Monit, 2019, 25:8457-8464.
[9]
Adewuya OA, Ajayi EA, Adebayo RA, et al. Serum uric acid and left ventricular hypertrophy in hypertensive patients in Ado-Ekiti[J]. Pan Afr Med J, 2020, 36:190.
Devereux RB, Alonso DR, Lutas EM, et al. Echocardiographic assessment of left ventricular hypertrophy:comparison to necropsy findings[J]. Am J Cardiol, 1986, 57(6):450-458.
[13]
Khoury PR, Mitsnefes M, Daniels SR, et al. Age-specific reference intervals for indexed left ventricular mass in children[J]. J Am Soc Echocardiogr, 2009, 22(6):709-714.
[14]
Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. J Am Soc Echocardiogr, 2015, 28(1):1-39.e14.
[15]
Nagueh SF, Smiseth OA, Appleton CP, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography:an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging[J]. Eur Heart J Cardiovasc Imaging, 2016, 17(12):1321-1360.
Gupta-Malhotra M, Banker A, Shete S, et al. Essential hypertension vs. secondary hypertension among children[J]. Am J Hypertens, 2015, 28(1):73-80.
[19]
Pruette CS, Fivush BA, Flynn JT, et al. Effects of obesity and race on left ventricular geometry in hypertensive children[J]. Pediatr Nephrol, 2013, 28(10):2015-2022.
[20]
Daniels SR, Loggie JM, Khoury P, et al. Left ventricular geometry and severe left ventricular hypertrophy in children and adolescents with essential hypertension[J]. Circulation, 1998, 97(19):1907-1911.
[21]
Hanevold C, Waller J, Daniels S, et al. The effects of obesity, gender, and ethnic group on left ventricular hypertrophy and geometry in hypertensive children:a collaborative study of the International Pediatric Hypertension Association[J]. Pediatrics, 2004, 113(2):328-333.
Ikejder Y, Sebbani M, Hendy I, et al. Impact of arterial hypertension on left atrial size and function[J]. Biomed Res Int, 2020, 2020:2587530.
[24]
Canciello G, Mancusi C, Izzo R, et al. Determinants of aortic root dilatation over time in patients with essential hypertension:the Campania Salute Network[J]. Eur J Prev Cardiol, 2020. DOI:10.1177/2047487320931630. Epub ahead of print.
[25]
Cuspidi C, Meani S, Fusi V, et al. Prevalence and correlates of left atrial enlargement in essential hypertension:role of ventricular geometry and the metabolic syndrome:the Evaluation of Target Organ Damage in Hypertension study[J]. J Hypertens, 2005, 23(4):875-882.
[26]
Sun HL, Pei D, Lue KH, et al. Uric acid levels can predict metabolic syndrome and hypertension in adolescents:a 10-year longitudinal study[J]. PLoS One, 2015, 10(11):e0143786.
[27]
Weaver DJ Jr. Uric acid and progression of chronic kidney disease[J]. Pediatr Nephrol, 2019, 34(5):801-809.
[28]
Bjornstad P, Laffel L, Lynch J, et al. Elevated serum uric acid is associated with greater risk for hypertension and diabetic kidney diseases in obese adolescents with type 2 diabetes:an observational analysis from the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) study[J]. Diabetes Care, 2019, 42(6):1120-1128.
[29]
Park JH, Jin YM, Hwang S, et al. Uric acid attenuates nitric oxide production by decreasing the interaction between endothelial nitric oxide synthase and calmodulin in human umbilical vein endothelial cells:a mechanism for uric acid-induced cardiovascular disease development[J]. Nitric Oxide, 2013, 32:36-42.
[30]
Lee SJ, Oh BK, Sung KC. Uric acid and cardiometabolic diseases[J]. Clin Hypertens, 2020, 26:13.
[31]
Jia GH, Habibi J, Bostick BP, et al. Uric acid promotes left ventricular diastolic dysfunction in mice fed a Western diet[J]. Hypertension, 2015, 65(3):531-539.
[32]
Bjelakovic B, Stefanutti C, Bonic D, et al. Serum uric acid and left ventricular geometry pattern in obese children[J]. Atheroscler Suppl, 2019, 40:88-93.
[33]
Tavil Y, Kaya MG, Sen N, et al. Assessment of left ventricular systolic and diastolic function by tissue Doppler analysis in patients with hypertension with or without hyperuricemia[J]. Blood Press Monit, 2008, 13(2):79-84.
